Aortic arch atheroma and the risk of stroke

Current Atherosclerosis Reports

Volumn 8, Issue 4, 2006, Pages 343-346

  Amarenco, Pierre ^a   Röther, Joachim ^b   Michel, Patrik ^b   Davis, Steven M ^b   Donnan, Geoffrey A ^b  

^a BICHAT HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; CLOPIDOGREL; WARFARIN;

AORTA ARCH; ATHEROMA; ATHEROSCLEROTIC PLAQUE; BLEEDING; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; ELDERLY CARE; HEART INFARCTION; HUMAN; PREVALENCE; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; WESTERN EUROPE;

AORTA, THORACIC; ASPIRIN; ATHEROSCLEROSIS; CEREBROVASCULAR ACCIDENT; HISTORY, 18TH CENTURY; HUMANS; RISK FACTORS; STROKE; TICLOPIDINE;

EID: 33745913903     PISSN: 15233804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11883-006-0014-z     Document Type: Review

References (26)

1. Amarenco P, Duyckaerts C, Tzourio C, et al.: The prevalence of ulcerated plaques in the aortic arch in patients with stroke. N Engl J Med 1992, 326:221-225
2. Khathibzadeh M, Mitusch R, Stierle U, et al.: Aortic atherosclerotic plaques as a source of systemic embolism. J Am Coll Cardiol 1996, 27:664-669
3. Amarenco P, Cohen A, Tzourio C, et al.: Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med 1994, 331:1474-1479.
4. Jones EF, Kalman JM, Calafiore P, et al.: Proximal aortic atheroma. An independent risk factor for cerebral ischemia. Stroke 1995, 26:218-224.
5. Tunick PA, Perez JL, Kronzon I: Protruding atheromas in the thoracic aorta and systemic embolization. Ann Intern Med 1991, 115:423-427.
6. Nihoyannopoulos P, Joshi J, Athanasopoulos G, Oakley CM: Detection of atherosclerotic lesions in the aorta by transesophageal echography. Am J Cardiol 1993, 71:1208-1212.
7. Stone DA, Hawke MW, LaMonte M, et al.: Ulcerated atherosclerotic plaques in the thoracic aorta are associated with cryptogenic stroke: a multiplane trasesophageal echocardiographic study. Am Heart J 1995, 130:105-108.
8. Di Tullio MR, Sacco RL, Gersony D, et al.: Aortic atheromas and acute ischemic stroke: a transesophageal echocardiographic study in an ethnically mixed population. Neurology 1996, 46:1560-1566.
9. Dávila-Román VG, Barzilai B, Wareing TH, et al.: Atherosclerosis of the ascending aorta. Prevalence and role as independent predictor of cerebrovascular events in cardiac patients. Stroke 1994, 25:2010-2016.
10. The French Study of Aortic Plaques in Stroke Group: Atherosclerotic disease of the aortic arch as a risk factor for reccurrent ischemic stroke. N Engl J Med 1996, 334:1216-1221.
11. Tunick PA, Rosenzweig BP, Katz ES, et al.: High risk for vascular events in patients with protruding aortic atheromas: a prospective study. J Am Coll Cardiol 1994, 23:1085-1090.
12. Mitusch R, Doherty C, Wucherpfennig H, et al.: Vascular events during follow-up in patients with aortic arch atherosclerosis. Stroke 1997, 28:36-39.
13. Dávila-Román V, Murphy SF, Nickerson NJ, et al.: Atherosclerosis of the ascending aorta is an independent predictor of long-term neurologic events and mortality. J Am Coll Cardiol 1999, 33:1308-1316.
14. Macleod MR, Amarenco P, Davis SM, Donnan GA: Atheroma of the aortic arch: an important and poorly recognised factor in the aetiology of stroke. Lancet Neurol 2004, 3:408-414.
15. Cohen A, Tzourio C, Bertrand B, et al.; on behalf of the FAPS Investigators: Aortic plaque morphology and vascular events. A follow-up study in patients with ischemic stroke. Circulation 1997, 96:3838-3841.
16. Tunick PA, Nayar AC, Goodkin GM, et al.; for the NYU Atheroma Group: Effect of treatment on the incidence of stroke and other emboli in 519 patients with severe thoracic aortic plaque. Am J Cardiol 2002, 90:1320-1325.
17. The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group: A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. Ann Neurol 1997, 42:857-865.
18. Mohr JP, Thompson JL, Lazar RM, et al.; for the Warfarin-Aspirin Recurrent Stroke Study Group: A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 2001, 345:1444-1451.
19. Petty GW, Brown RD Jr, Whisnant JP, et al.: Frequency of major complications of aspirin, warfarin, and intravenous heparin for secondary stroke prevention. A population-based study. Ann Intern Med 1999, 130:14-22.
20. CAPRIE Steering Committee: A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996, 348:1329-1339.
21. Harker LA, Marzec UM, Kelly AB, et al.: Clopidogrel inhibition of stent, graft, and vascular thrombogenesis with antithrombotic enhancement by aspirin in nonhuman primates. Circulation 1998, 98:2461-2469.
22. Steinhubl SR, Berger PB, Mann JT, et al.; for the CREDO Investigators: Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention. A randomized controlled trial. JAMA 2002, 288:2411-2420.
23. The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators: Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001, 345:494-502.
24. Bhatt DL, Fox KA, Hacke W, et al.; for the CHARISMA Investigators: Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006, In press.
25. Diener HC, Bogousslavsky J, Brass LM, et al.; on behalf of the MATCH Investigators: Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomized, double-blind, placebo-controlled trial. Lancet 2004, 364:331-337.
26. Amarenco P, Donnan GA: Should the MATCH results be extrapolated to all stroke patients and affect on-going trials evaluating clopidogrel plus aspirin? Stroke 2004, 35:2606-2608.